It potentially could be the first in a series that coaxes an HIV antibody to mature from a nascent form into a broadly neutralizing one.

Wednesday, May 29, 2019 Vaccine Elicits Antibody in Animals Akin to Precursors of Broadly Neutralizing HIV Antibodies in People NIAID scientists and colleagues have developed a vaccine that elicits an antibody in mice, rabbits and monkeys that is similar to the precursors of broadly neutralizing HIV antibodies found in some people living with HIV. This vaccine potentially could be the first in a series that coaxes an HIV antibody to mature from a nascent form into a broadly neutralizing one. The findings were published today in the journal Nature. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107